EFFICACY AND SAFETY OF PD-1/PD-L1 INHIBITORS USED IN THE TREATMENT OF PATIENTS WITH ADVANCED AND METASTATIC MELANOMA - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
作者：
Verma, J. [1 ]
Verma, D. [1 ]
Maria, A. [1 ]
机构：
[1] VRB Analyt Pvt Ltd, Thana, MH, India
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN154
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
[31]   The predictive value of PD-L1 expression in patients with advanced hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors: A systematic review and meta-analysis [J].
Yang, Yao ;
Chen, Dongbo ;
Zhao, Bigeng ;
Ren, Liying ;
Huang, Rui ;
Feng, Bo ;
Chen, Hongsong .
CANCER MEDICINE, 2023, 12 (08) :9282-9292
[32]   Efficacy and safety of PD-1/PD-L1 inhibitors in triple-negative breast cancer: a systematic review and meta-analysis [J].
Zhang, Meilin ;
Song, Jian ;
Yang, Hongguang ;
Jin, Feng ;
Zheng, Ang .
ACTA ONCOLOGICA, 2022, 61 (09) :1105-1115
[33]   Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis [J].
Liu, Surui ;
Gao, Wei ;
Ning, Yan ;
Zou, Xiaomeng ;
Zhang, Weike ;
Zeng, Liangjie ;
Liu, Jie .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[34]   Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis [J].
Quan Rao ;
Min Li ;
Wei Xu ;
Kai Pang ;
XiaoBo Guo ;
Dong Wang ;
Jun Liu ;
Wei Guo ;
ZhongTao Zhang .
Hepatology International, 2020, 14 :765-775
[35]   Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis [J].
Rao, Quan ;
Li, Min ;
Xu, Wei ;
Pang, Kai ;
Guo, XiaoBo ;
Wang, Dong ;
Liu, Jun ;
Guo, Wei ;
Zhang, ZhongTao .
HEPATOLOGY INTERNATIONAL, 2020, 14 (05) :765-775
[36]   The effects and safety of PD-1/PD-L1 inhibitors on head and neck cancer: A systematic review and meta-analysis [J].
Wang, Bi-Cheng ;
Cao, Ru-Bo ;
Li, Pin-Dong ;
Fu, Chen .
CANCER MEDICINE, 2019, 8 (13) :5969-5978
[37]   Response efficacy of PD-1 and PD-L1 inhibitors in salivary gland cancers: a systematic review and meta-analysis [J].
Babamohamadi, Zahra ;
Taherkhani, Amirreza ;
Yousefzadeh, Ali ;
Moradi, Ali ;
Heidari, Marziyeh ;
Nasab, Zahra Sadat Hoseini ;
Haghi, Seyedeh Mona ;
Afkhami, Ayda ;
Belbasi, Mohaddeseh ;
Noroozi, Masoud ;
Deravi, Niloofar .
FRONTIERS IN ONCOLOGY, 2025, 15
[38]   Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis [J].
Shen, Xian ;
Zhao, Bin .
BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
[39]   A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer [J].
Fan, Zhongyuan ;
Liang, Ye ;
Yang, Xuecheng ;
Li, Bin ;
Cui, Lili ;
Luo, Lei ;
Jia, Yuefeng ;
Wang, Yonghua ;
Niu, Haitao .
ONCOTARGETS AND THERAPY, 2019, 12 :1791-1801
[40]   Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis [J].
Nishijima, Tomohiro F. ;
Shachar, Shlomit S. ;
Nyrop, Kirsten A. ;
Muss, Hyman B. .
ONCOLOGIST, 2017, 22 (04) :470-479
12345